CLOSE X
GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
425.34 -3.87(-0.90%) NAV as on 20 Dec 2024
3.21 % 1 M
44.04 % 1 Y
25.17 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.95

As on 30 Nov, 2024
age-icon Age :

25 yrs 5 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

3,459.68 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.38

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2024
Others 3.50 %
Equity 96.50 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.87 %
Divi's Laboratories Ltd.6.42 %
Cipla Ltd.5.68 %
Max Healthcare Institute Ltd.5.66 %
Lupin Ltd.4.74 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs60.04
Hospital & Healthcare Services24.72
Medical Equipment/Supplies/Accessories4.02
Chemicals3.33
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)147.24252.90286.90281.32444.33
Net Assets(Rs Crores) (as on 31-Mar-2024) 853.49 1563.95 1778.29 1589.27 2626.34
Scheme Returns(%)(Absolute)-5.7873.5112.48-1.8658.88
B'mark Returns(%)(Absolute)NANANANANA
Category Rank13/7539/7548/7557/7614/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity425.34-3.87(-0.90%)NAV As on 20 Dec, 202414-Jul-1999Inception Date3,459.68AUM In Cr.44.04%1Y25.17%3Y29.24%5Y16.62%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.82-0.22(-0.56%)NAV As on 20 Dec, 202413-Jul-2018Inception Date5,044.63AUM In Cr.49.14%1Y25.86%3Y30.25%5Y23.43%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.82-0.25(-0.81%)NAV As on 20 Dec, 202428-Dec-2015Inception Date1,213.92AUM In Cr.42.34%1Y22.74%3Y27.36%5Y13.34%Since Inception
ITI Pharma & Healthcare Fund-Reg(G)Very HighEquity17.04-0.20(-1.18%)NAV As on 20 Dec, 202408-Nov-2021Inception Date217.92AUM In Cr.44.94%1Y20.89%3YNA%5Y18.64%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors